SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marshall Teitelbaum who wrote (1191)12/4/1997 6:44:00 PM
From: Rick Strange  Read Replies (3) of 2205
 
Marshall et al,

Well all the "knuckle biting" will be over by January 29th...we hope!
Depending upon other products being presented, that is a meeting that I might want to attend. Maybe the FDA will release the agenda tomarrow.

Talked to beth Kriegal, ATIS, today. She said that the cartilage trials will start in the first quarter as things now stand. She said that some had speculated that the trials would start before the end of the year but the company didn't want to repeat some of the mistakes that they had made with the Dermagraft trials in that they wanted to "optomize the theraputic range" before starting the trial. Maybe you would like to explain the meaning of that phrase for us non M.D. types? Does ATIS have a partner (S&N) to develop the cartilage product?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext